AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

Alligator Bioscience

Declaration of Voting Results & Voting Rights Announcements • Sep 30, 2025

3138_rns_2025-09-30_5d1a714c-2534-4856-bfe0-172f5320fe3b.pdf

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

CHANGE IN NUMBER OF SHARES AND VOTES IN ALLIGATOR BIOSCIENCE AB

During September 2025, the number of shares and votes in Alligator Bioscience AB ("Alligator Bioscience") has increased as a result of the exercise of warrants series TO 13, issued in connection with the rights issue of units carried out during December 2024 – February 2025.

As of 30 September 2025, the total number of shares and votes in Alligator Bioscience amounts to 43,813,672, of which all outstanding shares are ordinary shares with one vote each.

For further information, please contact:

Søren Bregenholt, CEO E-mail: [email protected] Phone: +46 (0) 46 540 82 00

This information is information that Alligator Bioscience is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 2025-09-30 15:00 CEST.